Immunotherapy in Patan

Allergen-specific immunotherapy has been used to treat allergic rhinitis and asthma for more than a century. The long-term efficacy of this therapy, most often used for patients with allergic disease who do not respond adequately to medications or avoidance measures, has been reaffirmed in several recently published research papers.

The long-term efficacy of this therapy, have been proven and supported by updated meta analysis:

Indication Allergen-specific immunotherapy is indicated in patients with allergic rhinitis/conjunctivitis and allergic asthma who have evidence of specific IgE antibodies to clinically relevant allergens. Skin prick testing is the preferred method of testing for specific IgE antibodies.

Ideal candidate : Patients with allergic rhinitis/conjunctivitis who wish to avoid the long-term use of pharmacological therapyexperience adverse effects of medications require high doses of medication, multiple medications, or both to maintain control of their disease; have symptoms that are not well controlled by pharmacological therapy or avoidance measures; allergic asthma who may be good candidates for immunotherapy include those who

VENOM IMMUNOTHERAPY:: Venom immunotherapy is indicated in individuals of all ages with severe systemic reactions to stinging insects, as well as in adults who experience generalized reactions that are limited to the skin. Severe systemic reactions to Hymenoptera venom are relatively uncommon, but can be fatal. The purpose of venom immunotherapy is to improve patient quality of life by allowing the patient to work or play outdoors without being concerned about the possibility of experiencing a serious allergic reaction. to reduce the severity of the reactions and the risk of fatality

Book an Appointment